PATENT CLAIM ANALYSIS

Application Number: 15974536
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "232800"]

Abstract:
The present invention relates to substituted 2-(morpholin-4-yl)-1,7-naphthyridine compounds of general formula (I) or (Ib), to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyperproliferative disease as a sole agent or in combination with other active ingredients.

Claim (Index 10):
A compound of general formula 12 in which R 1 , R 3  and R 4  are as defined in  claim 1  and X represents chloro, bromo or iodo.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 93.0
- Lexical Diversity: 1.72
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15159548', '15501079', '12729940', '13054853', '13970854']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7918516528197318
- 35 USC 102 Novelty (BERT): 0.566234664007709
- Combined Prediction Score: 0.7692899539385295
- Mean Citation Score: 384.060128
- Max Citation Score: 492.7248
- Similarity Product: 299.86550980052954

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test